Regenerex Pharma (RGPX) EPS (Basic) (2010 - 2025)

Regenerex Pharma (RGPX) has 13 years of EPS (Basic) data on file, last reported at -$0.0 in Q3 2025.

• EPS (Basic) for Q3 2025 came in at -$0.0, up 98.44% year-over-year; the trailing twelve-month figure through Sep 2025 was -$0.01 (up 97.95% YoY), and the FY2025 annual result was -$0.01, changed 0.0% from the prior year.
• EPS (Basic) fell to -$0.0 in Q3 2025 per RGPX's latest filing, from -$0.0 in the prior quarter.
• Over five years, EPS (Basic) peaked at -$0.0 in Q3 2022 and troughed at -$0.18 in Q3 2024.
• A 5-year average of -$0.03 and a median of -$0.0 in 2024 frame the typical range for EPS (Basic).
• The sharpest annual moves came in 2023 and 2024: EPS (Basic) slumped 63722.49% in 2023, then soared 99.38% in 2024.
• A 5-year view of EPS (Basic) shows it stood at -$0.0 in 2021, then surged by 55.47% to -$0.0 in 2022, then tumbled by 63722.49% to -$0.11 in 2023, then surged by 98.86% to -$0.0 in 2024, then sank by 131.09% to -$0.0 in 2025.
• Business Quant data shows RGPX's EPS (Basic) at -$0.0 in Q3 2025, -$0.0 in Q2 2025, and -$0.01 in Q1 2025.